Jiahui International Cancer Center Attracts Global Patients with Advanced CAR-T Therapy

---
Jiahui International Cancer Center Attracts Global Patients with Advanced CAR-T Therapy
Vote:
0 0
Previous ECW Announces US$3.5 Million First Emergency Response Grant in Bangladesh
Next MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model

Related News

CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting

SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan

CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China

PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

Weaving a Network of Care Together: Jiahui International Hospital (Shanghai) and NYU Shanghai Unveil Cooperative Program

U.S. FDA Approves Clinical Trial Application for IASO Bio's BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma

menu
menu